## BG: Bunge Global SA - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_20 -1.6% below STRENGTH zone (4.0-10.0%); PEG 1.71 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.9% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($90.43)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 1)

**1. Bunge Global SA (BG) director reports RSU dividend award and 33,441.8 shares owned**
- Source: Stock Titan | 20251203T210740 | Neutral | Relevance: 100%
- A director at Bunge Global SA (BG) received 18 restricted stock units (RSUs) as a dividend award on December 1, 2025, with a reference price of $96.47 per share. This transaction, not an open-market purchase, increases the director's total direct beneficial ownership to 33,441.7968 shares. The award was part of the company's long-term incentive plans.

**2. [Form 4] Bunge Global SA Insider Trading Activity**
- Source: Stock Titan | 20251203T210740 | Neutral | Relevance: 100%
- An executive at Bunge Global SA (BG) acquired 207 shares of company common stock on December 1, 2025, at $96.47 per share. These shares were granted as restricted stock units under the company's long-term incentive plans and tied to a dividend feature. Following this transaction, the Executive Vice President, Global Markets, Christos Dimopoulos, directly owned 104,743.808 shares of Bunge Global SA.

**3. Bunge Global SA (BG) Co-COO reports 283 RSU award and 124K+ shares owned**
- Source: Stock Titan | 20251203T210740 | Neutral | Relevance: 100%
- Bunge Global SA's Co-Chief Operating Officer received 283 restricted stock units (RSUs) on December 1, 2025, at a reference price of $96.47 per share, as part of the company's long-term incentive plans. This transaction increased the executive's direct beneficial ownership to 124,127.321 shares of common stock. The filing is categorized as a routine administrative equity compensation update.

**4. Bunge Global SA (BG) CHRO reports 131 restricted stock units via dividend feature**
- Source: Stock Titan | 20251203T210739 | Neutral | Relevance: 100%
- Bunge Global SA's Chief Human Resources Officer acquired 131 restricted stock units (RSUs) at $96.47 per share on December 1, 2025. These RSUs were granted as part of a dividend feature under the companyâ€™s long-term incentive plans. Following this transaction, the officer directly owns 25,528 shares of Bunge Global SA common stock.

**5. Bunge Global SA (BG) Chief Legal Officer now holds 85,504 shares after RSU award**
- Source: Stock Titan | 20251203T190740 | Neutral | Relevance: 100%
- Bunge Global SA's Chief Legal Officer, Joseph Podwika, received an award of 173 restricted stock units (RSUs) valued at $96.47 per share on December 1, 2025. This transaction, part of Bunge's long-term incentive plans, increases his direct beneficial ownership to 85,504 shares. The award reflects an alignment of executive compensation with shareholder interests through stock-based incentives.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | B of A Securiti | $112 | $95 | +18% |
| 2025-11-06 | Barclays | $120 | $105 | +14% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | B of A Securiti | main | Buy |
| 2025-11-06 | Barclays | up | Overweight |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 66.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Glencore Plc: 17.0% (+100.0%)
- Canada Pension Plan : 13.6% (+999418.6%)
- Vanguard Group Inc: 8.7% (+0.8%)
- Capital World Invest: 8.4% (+4.5%)
- Blackrock Inc.: 8.2% (-1.6%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.9% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.71 elevated, pricing in significant growth expectations. Forward P/E 10.7x attractive for 19% earnings growth. Revenue growth strong at 35% YoY. Analyst sentiment positive (2 raises, avg +16%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $17.2B |
| Beta | 0.78 |
| 52W Range | $67.40 - $99.55 |
| Short Interest | 3.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.71 |
| Forward P/E | 10.7 |
| Current P/E | 12.8 |
| YoY Growth | 19.3% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 1.2% to -1.6% (-2.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.6pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.17x) but short-term weakness (below SMA20). RSI neutral at 53. OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.63% (CS: 34) | Neutral |
| RSI_14 | 53.3 | Neutral |
| MACD Histogram | -0.22 | Bearish |
| vs SMA20 | 0.999x | Below |
| vs SMA50 | 1.042x | Above |
| vs SMA200 | 1.168x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $95.29
- **Stop Loss:** $90.43 (5.1% risk)
- **Target:** $100.15 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 195
- **Position Value:** $18,581.55
- **Portfolio %:** 18.58%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-02-11 (Est: $1.90)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.97 | $2.27 | +15.3% |
| 2025Q2 | $1.08 | $1.31 | +20.9% |
| 2025Q1 | $1.31 | $1.81 | +38.3% |
| 2024Q4 | $2.25 | $2.13 | -5.3% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*